Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 17, 2020
Health-related quality of life after traumatic brain injury: deriving value sets for the QOLIBRI-OS for Italy, The Netherlands and The United Kingdom
Daphne C Voormolen, Suzanne Polinder, Nicole von Steinbuechel, et al.
Pharmacoeconomics
|
April 17, 2020
International Valuation Protocol for the EQ-5D-Y-3L
Juan M Ramos-Goñi, Mark Oppe, Elly Stolk, et al.
Pharmacoeconomics - Open
|
April 27, 2022
Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada
Elisabetta Fenu, Vasily Lukyanov, Annabel Acs, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 5, 2022
Does Changing the Age of a Child to be Considered in 3-Level Version of EQ-5D-Y Discrete Choice Experiment-Based Valuation Studies Affect Health Preferences?
Juan M Ramos-Goñi, Anabel Estévez-Carrillo, Oliver Rivero-Arias, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 21, 2022
Budget impact of introducing subcutaneous vedolizumab as a maintenance therapy in biologic-naïve and biologic-experienced patients with ulcerative colitis in France
Mark Oppe, Bogdan Muresan, Katie Chan, et al.
Arthritis Care & Research
|
November 12, 2015
Cost-Effectiveness Model for Evaluating New Diagnostic Tests in the Evaluation of Patients With Inflammatory Arthritis at Risk of Having Rheumatoid Arthritis
Jolanda J Luime, Leander R Buisman, Mark Oppe, et al.
Arthritis Research & Therapy
|
June 12, 2016
A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis
Leander R Buisman, Jolanda J Luime, Mark Oppe, et al.
Medical Care
|
December 19, 2014
Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach
Juan M Ramos-Goñi, Jose L Pinto-Prades, Mark Oppe, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 18, 2021
Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms
Koonal K Shah, Bryan Bennett, Andrew Lenny, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
November 16, 2013
Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD
Clazien Bouwmans, Annemarie van der Kolk, Mark Oppe, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 17, 2020
Health-related quality of life after traumatic brain injury: deriving value sets for the QOLIBRI-OS for Italy, The Netherlands and The United Kingdom
Daphne C Voormolen, Suzanne Polinder, Nicole von Steinbuechel, et al.
Pharmacoeconomics
|
April 17, 2020
International Valuation Protocol for the EQ-5D-Y-3L
Juan M Ramos-Goñi, Mark Oppe, Elly Stolk, et al.
Pharmacoeconomics - Open
|
April 27, 2022
Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada
Elisabetta Fenu, Vasily Lukyanov, Annabel Acs, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 5, 2022
Does Changing the Age of a Child to be Considered in 3-Level Version of EQ-5D-Y Discrete Choice Experiment-Based Valuation Studies Affect Health Preferences?
Juan M Ramos-Goñi, Anabel Estévez-Carrillo, Oliver Rivero-Arias, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 21, 2022
Budget impact of introducing subcutaneous vedolizumab as a maintenance therapy in biologic-naïve and biologic-experienced patients with ulcerative colitis in France
Mark Oppe, Bogdan Muresan, Katie Chan, et al.
Arthritis Care & Research
|
November 12, 2015
Cost-Effectiveness Model for Evaluating New Diagnostic Tests in the Evaluation of Patients With Inflammatory Arthritis at Risk of Having Rheumatoid Arthritis
Jolanda J Luime, Leander R Buisman, Mark Oppe, et al.
Arthritis Research & Therapy
|
June 12, 2016
A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis
Leander R Buisman, Jolanda J Luime, Mark Oppe, et al.
Medical Care
|
December 19, 2014
Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach
Juan M Ramos-Goñi, Jose L Pinto-Prades, Mark Oppe, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 18, 2021
Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms
Koonal K Shah, Bryan Bennett, Andrew Lenny, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
November 16, 2013
Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD
Clazien Bouwmans, Annemarie van der Kolk, Mark Oppe, et al.
Page
of 6